Investigators are inspecting the now cooling Chevron El Segundo Refinery after and explosive fire swept through one of it's ...

Last fall, Midwest Messenger readers met Henry Dawson, a teen from Doniphan, Nebraska, who had a passion for finding ...

Fuel pump assembly Part Number USEP21053M includes application coverage for Lexus, Toyota, Infiniti, Honda, Ford and Lincoln ...

Jegs’ new 750-cfm carburetor delivers classic 4150 performance with modern tuning features at $599 for racers and street ...

The stock's return has trounced that of the S&P 500 and Nasdaq Composite over the past few years. As the world's largest company by market capitalization, Nvidia must grapple with high expectations.

(Bloomberg) --Chinese households are tiptoeing back into equities, driven in part by a stark reality: Almost nothing else looks worth buying. The CSI 300 Index has surged more than 25% since its April ...

Will robots really take your job? In this video, we explore the growing impact of automation and AI on the workforce. From historical fears to modern-day tech, we break down the truth behind the hype ...

BILLINGS, Mont. -- Young climate activists and their attorneys who won a landmark global warming trial against the state of Montana are trying to convince a federal judge to block President Donald ...

Figure Technology Solutions is the latest tech company to benefit from investors’ newfound (and apparently insatiable) appetite for initial public offerings. Shares surged more than 24% in their ...

Small-cap stock: Basilic Fly Studio share price will be in focus of the stock market investor on Monday, 15 September 2025, after the company announced that it has successfully raised ₹85 crore ...

Shares of UWM Holdings Corp (NYSE:UWMC) are trading higher Thursday afternoon. The move comes as investors digest a mixed bag of economic data that points towards a potential interest rate cut by the ...

aTyr Pharma's leading candidate is targeting a relatively large market with unmet needs. The biotech company is expected to release data from a phase 3 clinical trial soon. Though things look somewhat ...